{"id":231,"date":"2026-08-18T10:00:00","date_gmt":"2026-08-18T10:00:00","guid":{"rendered":"https:\/\/makrolife-biotech.com\/blog\/?p=231"},"modified":"2026-07-24T13:03:01","modified_gmt":"2026-07-24T13:03:01","slug":"eu-cosmetic-ingredient-restrictions-2026","status":"publish","type":"post","link":"https:\/\/makrolife-biotech.com\/blog\/eu-cosmetic-ingredient-restrictions-2026\/","title":{"rendered":"Proposed EU Cosmetic Ingredient Restrictions 2026: Which Formulations Could Be Affected?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The European Commission notified a new draft amendment to the EU Cosmetics Regulation on <strong>8 July 2026<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The proposal would prohibit or restrict several cosmetic ingredients based on new classifications and scientific assessments.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The consultation period is scheduled to remain open until <strong>6 September 2026<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The measure is still a draft and should not be presented as final adopted law.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Nevertheless, cosmetic manufacturers, responsible persons, safety assessors and raw-material suppliers should begin screening their portfolios now.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why has the new draft been proposed?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Part of the proposal is intended to reflect new classifications of substances as carcinogenic, mutagenic or toxic for reproduction under the EU Classification, Labelling and Packaging framework.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The relevant CLP amendment is scheduled to apply from <strong>1 February 2027<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The draft Cosmetics Regulation amendment also addresses several substances following opinions from the Scientific Committee on Consumer Safety.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Which ingredients are included in the proposal?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">According to the Commission notification, the draft notably proposes prohibitions for:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Benzophenone-1<\/li>\n\n\n\n<li>Benzophenone-2<\/li>\n\n\n\n<li>Basic Brown 16<\/li>\n\n\n\n<li>Basic Blue 99<\/li>\n\n\n\n<li>prostaglandin analogues<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">It also proposes new or revised restrictions for:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Butylated Hydroxyanisole, commonly known as BHA<\/li>\n\n\n\n<li>Butylparaben<\/li>\n\n\n\n<li>Cannabidiol, or CBD<\/li>\n\n\n\n<li>Hydroxyapatite in nano form<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The draft would additionally remove existing derogations concerning certain mercury-containing preservatives.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The final regulatory conditions may differ from the notified draft. Businesses should therefore track the final adopted text before making definitive legal conclusions.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Which cosmetic products may be affected?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The relevance depends on the ingredient and its function.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Potentially affected product categories may include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>UV-related and sun-care formulations<\/li>\n\n\n\n<li>hair-colouring products<\/li>\n\n\n\n<li>eyelash and eyebrow products<\/li>\n\n\n\n<li>products positioned around lash or hair growth<\/li>\n\n\n\n<li>preserved cosmetic formulations<\/li>\n\n\n\n<li>oral-care products containing hydroxyapatite<\/li>\n\n\n\n<li>CBD cosmetics<\/li>\n\n\n\n<li>products using butylparaben<\/li>\n\n\n\n<li>formulations containing BHA<\/li>\n\n\n\n<li>imported cosmetics using non-EU raw-material standards<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">A product should not be classified as affected based only on its marketing category. The actual INCI formula, raw-material composition and impurity profile must be assessed.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why should companies act before the regulation is final?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Early screening does not mean relabelling or reformulating immediately.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It means determining:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>which products contain potentially affected ingredients<\/li>\n\n\n\n<li>at what concentrations they are used<\/li>\n\n\n\n<li>which function the ingredient performs<\/li>\n\n\n\n<li>whether alternatives are available<\/li>\n\n\n\n<li>how long reformulation and testing would require<\/li>\n\n\n\n<li>whether existing stock and packaging could be affected<\/li>\n\n\n\n<li>which supplier documents need updating<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Waiting for the final publication may leave insufficient time for reformulation, stability testing, compatibility studies, safety reassessment and new packaging production.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Recommended steps for cosmetic companies<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">1. Screen the full product portfolio<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Search formulas and raw-material specifications for the substances named in the draft.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The review should include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>current products<\/li>\n\n\n\n<li>products under development<\/li>\n\n\n\n<li>discontinued products still on the market<\/li>\n\n\n\n<li>regional variants<\/li>\n\n\n\n<li>fragrance and colour variants<\/li>\n\n\n\n<li>raw materials with complex compositions<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">2. Contact suppliers<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Request current information on:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>INCI composition<\/li>\n\n\n\n<li>substance concentration<\/li>\n\n\n\n<li>impurities<\/li>\n\n\n\n<li>particle characteristics<\/li>\n\n\n\n<li>nano status<\/li>\n\n\n\n<li>safety data<\/li>\n\n\n\n<li>planned reformulations<\/li>\n\n\n\n<li>availability of compliant alternatives<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Supplier trade names may hide ingredients that are not obvious from internal product lists.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">3. Assess substitution impact<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Replacing an ingredient can affect:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>preservation<\/li>\n\n\n\n<li>colour<\/li>\n\n\n\n<li>stability<\/li>\n\n\n\n<li>texture<\/li>\n\n\n\n<li>sensory properties<\/li>\n\n\n\n<li>product performance<\/li>\n\n\n\n<li>packaging compatibility<\/li>\n\n\n\n<li>microbiological safety<\/li>\n\n\n\n<li>claims<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Reformulation should therefore be treated as a controlled development project, not only an ingredient-list update.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">4. Review the safety documentation<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">A formulation change may require updates to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>the Cosmetic Product Safety Report<\/li>\n\n\n\n<li>the Product Information File<\/li>\n\n\n\n<li>stability data<\/li>\n\n\n\n<li>microbiological assessments<\/li>\n\n\n\n<li>challenge testing<\/li>\n\n\n\n<li>packaging compatibility<\/li>\n\n\n\n<li>CPNP information<\/li>\n\n\n\n<li>the ingredient list and artwork<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The necessary scope depends on the significance of the change.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">5. Monitor the final regulation<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The draft should not be treated as the final legal text.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Companies should track:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>the end of the comment period<\/li>\n\n\n\n<li>the final adopted substances and conditions<\/li>\n\n\n\n<li>publication in the Official Journal<\/li>\n\n\n\n<li>application dates<\/li>\n\n\n\n<li>transition periods<\/li>\n\n\n\n<li>sell-through provisions<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Special attention for imported products<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Non-EU manufacturers may continue using ingredients permitted in their home market but restricted or prohibited in the EU.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Importers and EU responsible persons should not rely exclusively on a foreign-market compliance statement.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The complete formulation and relevant raw-material data must be assessed against the applicable EU requirements.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How Makrolife can support portfolio screening<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Makrolife can support cosmetic companies with:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>ingredient and formula portfolio screening<\/li>\n\n\n\n<li>identification of potentially affected products<\/li>\n\n\n\n<li>supplier-document reviews<\/li>\n\n\n\n<li>safety and toxicological assessments<\/li>\n\n\n\n<li>testing strategies for reformulated products<\/li>\n\n\n\n<li>CPSR and PIF updates<\/li>\n\n\n\n<li>label and INCI reviews<\/li>\n\n\n\n<li>coordination of stability and microbiological testing<\/li>\n\n\n\n<li>regulatory monitoring<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The immediate objective is not to predict the final wording. It is to identify where regulatory changes could create time, cost or launch risks.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Identify affected products early<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Companies using potentially affected ingredients should complete an initial portfolio screen while the proposal is still under review.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Request an EU Cosmetic Ingredient Portfolio Screening from Makrolife.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The European Commission notified a new draft amendment to the EU Cosmetics Regulation on 8 July 2026. The proposal would prohibit or restrict several cosmetic ingredients based on\u2026<\/p>\n","protected":false},"author":2,"featured_media":232,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,8,9],"tags":[18,31,19,14,30],"class_list":["post-231","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-beauty-and-supplements","category-regulatorik","category-regulatory","tag-18","tag-ban","tag-cosmetics","tag-eu","tag-ingredient"],"_links":{"self":[{"href":"https:\/\/makrolife-biotech.com\/blog\/wp-json\/wp\/v2\/posts\/231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makrolife-biotech.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makrolife-biotech.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makrolife-biotech.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/makrolife-biotech.com\/blog\/wp-json\/wp\/v2\/comments?post=231"}],"version-history":[{"count":1,"href":"https:\/\/makrolife-biotech.com\/blog\/wp-json\/wp\/v2\/posts\/231\/revisions"}],"predecessor-version":[{"id":233,"href":"https:\/\/makrolife-biotech.com\/blog\/wp-json\/wp\/v2\/posts\/231\/revisions\/233"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makrolife-biotech.com\/blog\/wp-json\/wp\/v2\/media\/232"}],"wp:attachment":[{"href":"https:\/\/makrolife-biotech.com\/blog\/wp-json\/wp\/v2\/media?parent=231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makrolife-biotech.com\/blog\/wp-json\/wp\/v2\/categories?post=231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makrolife-biotech.com\/blog\/wp-json\/wp\/v2\/tags?post=231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}